How are they Solving it?

Our team began researching antioxidant compounds over a decade ago, leading to the discovery of a bioactive compound effective in controlling diabetic cardiomyopathies and hyperglycemia. The team tested various strains of the Campomanesia family on 380 mice during the in-vivo phase, yielding significant results. The liposoluble oil developed promotes glycemic control through free diffusion across cell membranes, facilitating glucose uptake. It effectively controls hyperglycemia without inducing hypoglycemia, acts twice as insulin, and exhibits antioxidant properties that reverse metabolic deterioration. Our product is expected to be a game-changer for diabetic preventive care.